QNCX Stock: Quince Therapeutics, Inc. Stock Price, Analysis & Insights
Get live qncx stock price $3.12, comprehensive Quince Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time qncx stock data and investment insights.
Loading chart...
Company Overview
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Company Information
- CEO
- Dirk Thye
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 36
Contact Information
- Website
- https://www.quincetx.com
- Address
- 601 Gateway Blvd
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Quince Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Dirk Thye, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Quince Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 173.7 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Quince Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Quince Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Quince Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Quince Therapeutics, Inc.
- ⚠Investors should consider how Quince Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
173.73M
P/E Ratio
-2.60
Beta
1.15
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 173.73M market capitalization
- Trading Volume: 1.20M shares traded today
- Price Range: 52-week range of $0.72 - $3.25
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Quince Therapeutics, Inc.
Quince Therapeutics, Inc. (QNCX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 173.73M, the company represents a significant player in its market. The stock is currently trading at $3.12 with a positivedaily change of 16.85%.
The company's 36 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.60, beta of 1.15, and 52-week price range from $0.72 to $3.25when evaluating investment opportunities.
Why Invest in Quince Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Dirk Thye
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.